[Federal Register: August 29, 2003 (Volume 68, Number 168)]
[Notices]               
[Page 52055-52056]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29au03-87]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

 
Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Inter Company Collaboration for AIDS Drug 
Development

    Notice is hereby given that, on August 5, 2003, pursuant to section 
6(a) of the

[[Page 52056]]

National Cooperative Research and Production Act of 1993, 15 U.S.C. 
4301 et seq. (``the Act''), Inter Company Collaboration for AIDS Drug 
Development has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership status. The notifications were filed for the purpose of 
extending the Act's previsions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, although there are no other changes in the membership, 
Collaboration member Pfizer, Inc. of New York, NY, has acquired 
Collaboration member Pharmacia Corporation of Peapack, NJ.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Inter Company Collaboration for AIDS 
Drug Development intends to file additional written notification 
disclosing all changes in membership.
    On May 27, 1993, Inter Company Collaboration for AIDS Drug 
Development filed its original notification pursuant to section 6(a) of 
the Act. The Department of Justice published a notice in the Federal 
Register pursuant to section 6(b) of the Act on July 6, 1993 (58 FR 
36223).
    The last notification was filed with the Department on April 4, 
2003. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on May 16, 2003 (68 FR 26648).

Dorothy B. Fountain,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 03-22079 Filed 8-28-03; 8:45 am]

BILLING CODE 4410-11-M